Monthly Archives: March 2023
Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn’s Disease: a Pragmatic Randomized Trial
Tumor Necrosis Factor inhibitors (TNFi), including infliximab and adalimumab, are a mainstay of pediatric Crohn’s disease (PCD) therapy; however, non-response and loss of response is common. As combination therapy with methotrexate may improve response… Continue reading
Posted in News
Comments Off on Comparative Effectiveness of Anti-TNF in Combination with Low Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn’s Disease: a Pragmatic Randomized Trial
ODEVIXIBAT TREATMENT INDUCES BILIARY BILE ACID SECRETION IN RESPONSIVE PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY (PFIC2)
Posted in News
Comments Off on ODEVIXIBAT TREATMENT INDUCES BILIARY BILE ACID SECRETION IN RESPONSIVE PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY (PFIC2)
Should POEM be the Rescue Therapy of Choice After Failed Laparoscopic Heller Myotomy?
Posted in News
Comments Off on Should POEM be the Rescue Therapy of Choice After Failed Laparoscopic Heller Myotomy?
Estimated Burden of Screening for Barrett’s Esophagus in the United States
Posted in News
Comments Off on Estimated Burden of Screening for Barrett’s Esophagus in the United States
Estimated Burden of Screening for Barrett’s Esophagus in the United States
Posted in News
Comments Off on Estimated Burden of Screening for Barrett’s Esophagus in the United States
Our New President—Barbara H. Jung, MD, AGAF
We are excited to introduce our next American Gastroenterological Association (AGA) Institute President, Barbara H. Jung, MD, AGAF. We were both among her mentors from earlier in her sterling academic career. Barbara becomes the 118th President of the … Continue reading
Posted in News
Comments Off on Our New President—Barbara H. Jung, MD, AGAF
Transmission of the potential pathogen atypical enteropathogenic E. coli by fecal microbiota transplant.
Posted in News
Comments Off on Transmission of the potential pathogen atypical enteropathogenic E. coli by fecal microbiota transplant.
A-to-I RNA-Editing: an epigenetic hallmark cannot be ignored in silencing the tumor microenvironment and is promising in predicting immunotherapy response for esophageal squamous cell carcinoma
Posted in News
Comments Off on A-to-I RNA-Editing: an epigenetic hallmark cannot be ignored in silencing the tumor microenvironment and is promising in predicting immunotherapy response for esophageal squamous cell carcinoma
ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats
Excess copper causes hepatocyte death in hereditary Wilson disease (WD). Current WD treatments by copper-binding chelators may gradually reduce copper overload; they fail, however, to bring hepatic copper close to normal physiological levels. Consequen… Continue reading
Posted in News
Comments Off on ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats
Liver SOL in a case of colon cancer, a red herring
Posted in News
Comments Off on Liver SOL in a case of colon cancer, a red herring